Cargando…
Exendin-4 Induces Cell Adhesion and Differentiation and Counteracts the Invasive Potential of Human Neuroblastoma Cells
Exendin-4 is a molecule currently used, in its synthetic form exenatide, for the treatment of type 2 diabetes mellitus. Exendin-4 binds and activates the Glucagon-Like Peptide-1 Receptor (GLP-1R), thus inducing insulin release. More recently, additional biological properties have been associated to...
Autores principales: | Luciani, Paola, Deledda, Cristiana, Benvenuti, Susanna, Squecco, Roberta, Cellai, Ilaria, Fibbi, Benedetta, Marone, Ilaria Maddalena, Giuliani, Corinna, Modi, Giulia, Francini, Fabio, Vannelli, Gabriella Barbara, Peri, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750033/ https://www.ncbi.nlm.nih.gov/pubmed/23990978 http://dx.doi.org/10.1371/journal.pone.0071716 |
Ejemplares similares
-
PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008) -
In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010) -
Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006) -
The V(2) receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells
por: Marroncini, G., et al.
Publicado: (2022) -
Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4
por: Larsson, Martin, et al.
Publicado: (2016)